Table II.

Details of the patients who had a recurrence of infection.

Site	Aetiology	C-M stage	Initial surgery	Months to recurrence	Initial microbiology	Recurrent microbiology	Revision treatment
Calcaneum	Heel shift osteotomy	III BL	Excision 6 ml CG Direct closure of previous ALT flap	4.8	MSSA	MSSA	Revision excision 8 ml CG Gracilis muscle flap
Distal radius	Fracture with ORIF	III A	Excision 4 ml CG	5.2	No growth	MSSA Serratia marcescens	Drainage of abscess only
Tibial diaphysis	Gunshot wound to tibia	III BL	Excision 30 ml CG LD flap	7.1	MSSA	MSSA Streptococcus agalactiae	Revision excision 20 ml CG
Femoral diaphysis	Open fracture with ORIF	III BL	Excision 20 ml CG external fixator	18.8	Resistant Pseudomonas spp	Resistant Pseudomonas spp	Revision excision+ Amikacin in CaSO4
Femoral diaphysis	Open fracture with ORIF	III BL	Excision 10 ml CG direct closure	23.8	MSSA	MSSA	Revision with 20 ml CG
Tibia + talus	Charcot ankle with failed fusion	IV BLS	Excision, 20 ml CG+ IMN	53.1	Acinetobacter	Acinetobacter	Amputation

ALT, anterolateral thigh flap; CG, Cerament with gentamicin; C-M, Cierny-Mader; IMN, intramedullary nail; LD, latissimus dorsi free flap; MSSA, methicillin-sensitive Staphylococcus aureus; ORIF, open reduction and internal fixation.